Contact our breast care nurses 0808 800 6000

Breast Cancer Now media statements

145 results
Media Statement
We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes

In response to research published in Genome Medicine, and part-funded by Breast Cancer Now, which suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes, Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said:

15 Jun 2022